Julie A Johnson

Julie A Johnson Pharm.D.

Dean & Distinguished Professor

Department: Dean's Office
Business Phone: (352) 273-6309
Business Email: julie.johnson@ufl.edu

About Julie A Johnson

Julie A. Johnson, Pharm.D., is dean of the University of Florida College of Pharmacy and distinguished professor of Pharmacy and Medicine. She received her B.S. in Pharmacy from the Ohio State University and her Pharm.D. from the University of Texas at Austin and the UT Health Science Center at San Antonio. She completed a post-doctoral fellowship in cardiovascular pharmacology/pharmacokinetics at Ohio State.

Johnson’s research focuses on cardiovascular pharmacogenomics and genomic medicine implementation. She is an internationally-recognized leader in pharmacogenomics and genomic medicine, with over 290 peer reviewed publications and nearly $45 million in research funding as principal investigator. In 2015, 2016, 2017 she was named a Thomson Reuters (now Clarivate Analytics) Highly Cited Scientist in Pharmacology and Toxicology, and in 2018 in the Cross Discipline category, indicating she is in the top 1% of the most highly cited scientists in the field globally.

Johnson has served on the Nonprescription Drugs Advisory Committee of the FDA, the XNDA Study Section at NIH, and in numerous scientific capacities with NIH’s NHLBI. She has had leadership roles in the American College of Clinical Pharmacy (ACCP), the American Heart Association (AHA), and the American Society of Clinical Pharmacology and Therapeutics (ASCPT), for which she completed her term as President in 2017. She is an elected fellow of the ACCP, the AHA and the American College of Clinical Pharmacology (ACCP-Pharmacology). Johnson was elected to the National Academy of Medicine (formerly Institute of Medicine) in 2014 and has received numerous other awards including teaching awards from both the University of Tennessee (1996) and the University of Florida (2001); the Ohio State University Alumni Association William Oxley Thompson Award for early career achievement (1997), Leon I Goldberg Young Investigator Award from the ASCPT (2004), Paul Dawson Biotechnology Research Award, American Association of Colleges of Pharmacy (AACP) (2007), Therapeutic Frontiers Award (2009) and Russell R Miller Award for Contributions to the Literature (2010), both from ACCP, the Southeastern Universities Research Association Distinguished Scientist Award (2015); AACP Volwiler Research Achievement Award (2016), the ACCP-Pharmacology Distinguished Scientist Award (2019), and ACCP Paul Parker Medal (2019), among others.

Honors & Awards

Volwiler Research Achievement Award
2016 · American Association of Colleges of Pharmacy
Highly Cited Scientist
2015-2018 · Clarivate Analytics
Distinguished Scientist Award
2015 · Southeastern Universities Research Associate
Elected Member
2014 · National Academy of Medicine
Honorary Fellow Award
2014 · American College of Clinical Pharmacology
Russell Miller Award for Contribution to the Literature
2010 · American College of Clinical Pharmacy
Therapeutic Frontiers Award
2009 · American College of Clinical Pharmacy
Fellow
2009 · American Heart Association; Functional Genomics and Translational Biology Council
Paul Dawson Biotechnology Research Award
2007 · American Association of Colleges of Pharmacy
Leon I. Goldberg Young Investigator Award
2004 · American Society for Clinical Pharmacology and Therapeutics
William Oxley Thompson Alumni Award
1997 · The Ohio State University
Fellow
1996 · American College of Clinical Pharmacy

Publications

2019 Genetics in medicine : official journal of the American College of Medical Genetics
2018 Expert Opinion on Drug Metabolism & Toxicology
2015 Trends in Cardiovascular Medicine
2014 Journal of the American Society of Hypertension
2014 American Journal of Medical Genetics. Part C: Seminars in Medical Genetics
2013 World Journal of Cardiovascular Diseases
2012 Clinical Pharmacology & Therapeutics
2010 Pharmacogenetics and Genomics
2009 New England Journal of Medicine
2008 Clinical and Experimental Allergy
2007 Pharmacotherapy
2006 Annals of Internal Medicine
2005 Current Opinion in Molecular Therapeutics
2005 The Pharmacogenomics Journal
2004 Clinical Pharmacology & Therapeutics
2002 Briefings in Functional Genomics & Proteomics
2001 American Journal of Pharmacogenomics
2000 International Journal of Clinical Pharmacology and Therapeutics
2000 Journal of Pharmacology and Experimental Therapeutics
2000 Journal of Chromatography B: Biomedical Sciences and Applications
1997 Journal of Pharmaceutical Sciences
1995 Journal of Cardiovascular Pharmacology
1995 British Journal of Clinical Pharmacology
1992 Clinical Pharmacology & Therapeutics
1989 Journal of Pharmacokinetics and Pharmacodynamics
1985 Clinical Pharmacy
1985 Journal of Quality Assurance

Grants

September 2018ACTIVE
Sparking Advancements in Genomic Medicine?
NATL INST OF HLTH NHGRI · Principal Investigator
January 2018ACTIVE
Training Program for Applied Research and Development in Genomic Medicine
NATL INST OF HLTH NHGRI · Principal Investigator
July 2016 – June 2019
A stem cell tactic to promote personalized medicine
NATL INST OF HLTH NIGMS · Project Manager
July 2016 – June 2018
A Stem Cell Tactic to Promote Personalized Medicine in Hypertension
AMER HEART ASSOCIATION ·
October 2015 – March 2019
OneFlorida Clinical Research Consortium Phase II
PATIENT-CENTERED OUTCOMES RES INST · Project Manager
July 2014 – December 2015
Using Different OMICS for the Identification of Novel Biomarkers of Blood Pressure Response to Antihypertensive Drugs
AMER HEART ASSOCIATION · Principal Investigator
June 2013 – September 2018
Genomic Medicine Implementation: The Personalized Medicine Program
NATL INST OF HLTH NHGRI · Principal Investigator
March 2011 – February 2016
Secondary Prevention of Subcortical Stroke Prevention
NATL INST OF HLTH NINDS · Principal Investigator
August 2010 – July 2017
Pharmacogenomic Evaluation of Antihypertensive Responses.
NATL INST OF HLTH NIGMS · Principal Investigator
July 2007 – August 2016
CTSI
UF RESEARCH FOU · Project Manager

Patents

Published May 2009
Use of Genetic Determinants in Cardiovascular Risk Assessment
US 2010-0021903-A1
Published August 2007
B-Blocker Pharmacogenetics in Heart Failure
US-2008-0269346-A1
Published July 2003
Beta-Adrenoceptor Genetic Polymorphisms and Obesity
US-2004-0033524
Published February 2002
Methods of Diagnosing Obesity and Products Related Thereto
US-2002-0187491

Education

1987-1989
Postdoctoral Fellowship in Pharmacokinetics/Clinical Pharmacology
The Ohio State University
1987
Pharm.D.
The University of Texas at Austin and The University of Texas Health Science Center at San Antonio
1985
B.S.
The Ohio State University